WB
VRTX icon

Webster Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Webster Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$4.85K – 696
2025
Q1 		$4.85K Hold
10
– – ﹤0.01% 529
2024
Q4 		$4.03K Hold
10
– – ﹤0.01% 545
2024
Q3 		$4.65K Hold
10
– – ﹤0.01% 543
2024
Q2 		$4.69K Sell
10
-9
-47% -$3.91K ﹤0.01% 553
2024
Q1 		$7.94K Buy
+19
New +$8.03K ﹤0.01% 494
2018
Q1 		– Sell
-28
Closed -$4K – 563
2017
Q4 		$4K Buy
+28
New +$4.15K ﹤0.01% 539

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Webster Bank's VRTX Position: Q2 2025 in Review

Webster Bank sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 10 shares — an estimated $4.85K sold.

Webster Bank first reported a position in VRTX in Q4 2017 and held it in 6 quarters. The position peaked at $7.94K in Q1 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Webster Bank reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Webster Bank sold 10 Vertex Pharmaceuticals shares in Q2 2025, an estimated $4.85K.
  • Webster Bank first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • Webster Bank's Vertex Pharmaceuticals position peaked at $7.94K in Q1 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Webster Bank's 13F filing for Q2 2025, filed 8 Jul 2025.